SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Vista Pharmaceuticals receives EIR for formulation facility at Telangana

08 Sep 2017 Evaluate

Vista Pharmaceuticals’ formulation facility at APIIC Industrial Estate, Nalgonda District in state of Telangana, which was inspected by US Food & Drug Administration (USFDA) during September 2016, has received Establishment Inspection Report (EIR), thereby confirming the closure of the inspection.

Vista Pharmaceuticals is engaged in manufacturing and selling of pharmaceutical, medical and veterinary preparations. The company also sells the products to its related companies, which are engaged in the manufacture of formulations.



Vista Pharma Share Price

7.60 0.19 (2.56%)
24-Jun-2026 12:46 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1876.30
Dr. Reddys Labs. 1337.85
Cipla 1445.00
Zydus Lifesciences 1102.55
Lupin 2384.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: